Baxter International | BAX - Ebitda

Prix De L'Action
18.16
Variation Quotidienne
-0.25 -1.36%
Mensuellement
6.07%
Annuel
-39.91%
Q2 Prévisions
17.77




Ebitda Changement Date
Abbott USD 3.27B 178M 2025-12
AngioDynamics USD 5.94M 3.78M 2025-09
Artivion USD 22.72M 1.84M 2025-12
AtriCure USD 19.86M 2.06M 2025-12
Avanos Medical USD 10M 73.9M 2025-09
Baxter International USD 426M 36M 2025-09
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Boston Scientific USD 1.16B 213M 2025-12
Cooper Companies USD 323.4M 13.2M 2025-12
Dexcom USD 422.2M 53.8M 2025-12
Edwards Lifesciences USD 70.1M 394.2M 2025-12
Fresenius EUR 850M 22M 2025-09
Globus Medical USD 280.46M 27.86M 2025-12
Halozyme Therapeutics USD 21.9M 226.34M 2025-12
ICU Medical USD 98.19M 27.67M 2025-12
Insulet USD 194M 34M 2025-12
Integra LifeSciences USD 104.21M 25.76M 2025-12
Intuitive Surgical USD 1.09B 165.5M 2025-12
J&J USD 7.19B 2.32B 2025-12
Laboratory Of America USD 588.1M 24.1M 2025-12
Masimo USD 91.9M 19.9M 2025-09
Medtronic USD 2.93B 482M 2025-12
Merit Medical Systems USD 97.23M 17.69M 2025-12
Quest Diagnostics USD 557M 20M 2026-03
Smith & Nephew USD 796M 139M 2025-12
Stryker USD 1.67B 206M 2025-09
Tandem Diabetes Care USD 32.9M 30.13M 2025-12
Teleflex USD -328.81M 536.43M 2025-09
Terumo JPY 69.99B 3.22B 2025-12
Zimmer Biomet Holdings USD 759M 120.8M 2025-12